Sugi Predict

Sugi Predict / Compounds / Moexipril

Moexipril

Moexipril

SCHEMBL6508276

CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O.CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Moexipril. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ ACE known ✓ P12821 15/20 1.00
▸ PDE3A Q14432 1/20 1.00
▸ ABCB11 O95342 2/20 0.80
▸ LMNA P02545 1/20 0.64
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ AGTR2 P50052 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Moexipril SCHEMBL29376544 1.00 ACE (1.00) ACEPDE3AABCB11LMNASMN1; SMN2
Moexipril SCHEMBL683321 1.00 ACE (1.00) ACEPDE3AABCB11LMNASMN1; SMN2
Moexipril SCHEMBL22175779 1.00 ACE (1.00) ACEPDE3AABCB11LMNASMN1; SMN2
Moexipril SCHEMBL34030 1.00 ACE (1.00) ACEPDE3AABCB11LMNASMN1; SMN2
Moexipril SCHEMBL678818 1.00 ACE (1.00) ACEPDE3AABCB11LMNASMN1; SMN2
Moexipril SCHEMBL5159178 0.99 ACE (0.98) ACEPDE3AABCB11LMNASMN1; SMN2
Moexipril SCHEMBL40877 0.99 ACE (0.98) ACEPDE3AABCB11LMNASMN1; SMN2
Moexipril SCHEMBL14660386 0.99 ACE (0.98) ACEPDE3AABCB11LMNASMN1; SMN2
Moexipril SCHEMBL30903896 0.99 ACE (0.98) ACEPDE3AABCB11LMNASMN1; SMN2
Moexipril SCHEMBL5386742 0.99 ACE (0.98) ACEPDE3AABCB11LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005079772-A2 COMBINATION OF (S)-AMLODIPINE AND AN ACE INHIBITOR, AND METHODS FOR REDUCING HYPERTENSION SEPRACOR INC. (US) 2005-09-01 — — WO disclosed